Journal of Infectious Disease and Pathology
Open Access

Herpes simplex virus (HSV); Molecular diagnostics; Polymerase chain reaction (PCR); Loop-mediated isothermal amplification (LAMP); Nucleic acid hybridization; Next-Generation Sequencing (NGS)

Introduction

Herpes Simplex Virus (HSV) infections are among the most common viral infections worldwide, affecting a substantial portion of the global population. HSV is classified into two types: HSV-1, commonly associated with oral herpes (cold sores), and HSV-2, predominantly responsible for genital herpes. Accurate and timely diagnosis of HSV infections is essential for effective patient management, treatment, and prevention of transmission. Molecular approaches have revolutionized the detection of HSV, providing sensitive, specific, and rapid diagnostic tools. This article explores the various molecular techniques employed in the detection of HSV infections [1].

Traditionally, laboratory diagnosis of HSV has relied on culturebased methods, serological assays, and antigen detection techniques. While these methods have been invaluable for many years, they have limitations, including variable sensitivity, the need for viral culture facilities, and the inability to differentiate between HSV-1 and HSV-2 in some cases. However, over the past few decades, significant strides have been made in the field of diagnostic virology, leading to the development and widespread adoption of innovative techniques that have transformed the laboratory diagnosis of HSV [2].

This article explores the frontiers of laboratory diagnosis in the context of HSV infections. It delves into the innovative techniques that have emerged as game-changers in the field, offering improved sensitivity, specificity, speed, and convenience. These innovative approaches not only enhance our ability to diagnose HSV infections accurately but also provide invaluable insights into viral genomics, epidemiology, and treatment response.

In the following sections, we will embark on a journey through these groundbreaking diagnostic methods, unveiling their principles, applications, and implications for clinical practice and public health. From advanced molecular assays and next-generation sequencing to novel point-of-care technologies and CRISPR-based diagnostics, the arsenal of tools available for diagnosing HSV has expanded significantly, promising a brighter future in the battle against this ubiquitous viral foe [3].

Specimen collection

Specimens obtained from vesicular lesions within the first three days after their appearance are the specimens of choice, but other lesion material from older lesions or swabs of genital secretions should be obtained if suspicion of HSV infection is high. Once crusting and healing have begun, the recovery rate of HSV drops sharply. The use of alcohol or iodophors to cleanse the lesions may inactivate the virus and should therefore be avoided. Calcium alginate swabs are toxic to HSV and therefore should not be used.

Polymerase chain reaction

Polymerase Chain Reaction, or PCR, is the gold standard for detecting HSV DNA. This molecular technique amplifies specific segments of the viral genome, allowing for highly sensitive detection, even in cases with low viral loads. PCR can differentiate between HSV- 1 and HSV-2 and is used for various clinical purposes, including the diagnosis of genital and oral herpes, herpes encephalitis, and neonatal herpes [4]. Real-time PCR, in particular, offers quantitative information about viral load, aiding in disease monitoring and treatment assessment.

Loop-mediated isothermal amplification

Loop-Mediated Isothermal Amplification is an emerging molecular technique that offers advantages similar to PCR but operates under isothermal conditions, eliminating the need for thermal cycling. LAMP is highly specific and can detect HSV DNA rapidly. Its simplicity, speed, and potential for point-of-care applications make it a promising tool for resource-limited settings [5,6].

Nucleic acid hybridization

Nucleic acid hybridization assays, such as in-situ hybridization (ISH) and fluorescence in-situ hybridization (FISH), are used to detect HSV DNA within clinical samples. ISH and FISH utilize fluorescent or enzyme-labeled DNA probes that bind specifically to viral DNA in tissue or cytological specimens. These techniques are valuable in diagnosing herpes keratitis, genital herpes, and herpesvirus-associated malignancies.

Next-generation sequencing

Next-generation sequencing technologies have revolutionized the field of virology, enabling comprehensive genome analysis and viral discovery. While not typically employed in routine clinical diagnosis due to cost and complexity, NGS can be utilized for research, outbreak investigations, and in cases where conventional methods fail to provide a diagnosis. NGS can help identify viral genetic variants and understand HSV epidemiology [7].

Digital PCR

Digital PCR is an emerging technology that offers absolute quantification of target DNA. This method partitions the PCR reaction into thousands of individual reactions, providing an accurate viral load measurement. dPCR is particularly valuable for monitoring the progression of HSV infections and assessing the efficacy of antiviral therapy.

Multiplex PCR panels

Multiplex PCR panels simultaneously detect multiple pathogens, including HSV, in a single assay. These panels offer rapid results and are valuable for screening and diagnosing infectious diseases. Multiplex PCR is especially useful when clinicians need to differentiate between HSV and other causes of similar clinical symptoms.

CRISPR-based assays

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology has been adapted for the diagnosis of infectious diseases, including HSV. CRISPR-based assays can detect viral DNA with high specificity. They work by using CRISPR-Cas proteins to target and cleave HSV DNA, leading to a detectable signal. This innovative approach offers the potential for highly specific and rapid HSV detection [8].

Discussion

The molecular approaches discussed in this article have significantly advanced our ability to detect Herpes Simplex Virus (HSV) infections with unprecedented sensitivity and specificity. The application of these techniques has had a profound impact on clinical diagnosis, epidemiological studies, and research into HSV biology. Polymerase Chain Reaction (PCR) remains the gold standard for HSV detection due to its exceptional sensitivity, specificity, and ability to distinguish between HSV-1 and HSV-2. This accuracy is paramount for guiding clinical management decisions, such as antiviral therapy initiation [9].

Molecular approaches like real-time PCR and Digital PCR (dPCR) provide quantitative information about viral load. This feature is especially valuable for monitoring disease progression, assessing the efficacy of antiviral treatments, and understanding the dynamics of HSV infections. Quantitative data can aid clinicians in tailoring treatment regimens to individual patients' needs. Molecular techniques, including Next-Generation Sequencing (NGS), have enabled researchers to delve deeper into HSV epidemiology, genetic diversity, and the emergence of drug-resistant strains. These insights are critical for public health efforts, such as vaccine development and outbreak control [10].

Conclusion

Molecular approaches have revolutionized the detection and diagnosis of Herpes Simplex Virus (HSV) infections, providing clinicians and researchers with powerful tools to better understand, manage, and control this prevalent viral disease. The high sensitivity and specificity of techniques like PCR and LAMP enable accurate diagnosis, differentiation of HSV types, and monitoring of viral load. These advancements have led to improved patient care, timely initiation of antiviral therapy, and enhanced disease surveillance.

However, challenges remain in ensuring the accessibility and affordability of these molecular methods, particularly in resourcelimited settings. The development of point-of-care tests and the continued refinement of diagnostic technologies will be crucial in addressing these challenges and expanding the reach of accurate HSV diagnosis.

Moreover, molecular diagnostics play a pivotal role in epidemiological studies and virological research, offering insights into viral genetic diversity, drug resistance, and transmission dynamics. As technology continues to advance, the field of HSV diagnostics will likely witness further innovations, ultimately contributing to better patient outcomes and a deeper understanding of HSV infections.

Acknowledgement

None

Conflict of Interest

None

1. Liesegang TJ (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20: 1-13.

Indexed at, Google Scholar, Crossref

2. Souza PM, Holland EJ, Hunag AJ, (2003) Bilaterail herpetic keratoconjunctivitis. Ophthalmology 110: 493-496.

Indexed at, Google Scholar, Crossref

3. Liesegang TJ (2001)Herpes simplex virus epidemiology and ocular importance. Cornea 20: 1-13.

Indexed at, Google Scholar, Crossref

4. Alche LE, Barquero AA, Sanjuan NA, Coto CE, (2002)An antiviral principle present in a purified fraction fromMelia azedarachL. leaf aqueous extract retains herpes simplex virus type 1 propagation. Phytother Res 16: 348-352.

Indexed at, Google Scholar                      Crossref

5. Madureira AM, Ascenso JR, Valdeira L, Duarte A, Frade JP, et al. (2003)Evaluation of the antiviral and antimicrobial activities of triterpenes isolated fromEuphorbia segetalis. Nat Prod Res 17: 375-380.

Indexed at, Google Scholar, Crossref

6. Kupchan SM, Altland HW, (1973)Tumor inhibitor. Structural requirements for tumor-inhibitory activity a mong benzylisoquinoline alkaloids and related synthetic compounds. J Med Chem16: 913-917.

Indexed at, Google Scholar, Crossref

7. Unander DW, Webster GL, Blumberg BS, (1995)Usage and bio-assays inPhyllanthus(Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J Ethnopharmacol 45: 1-18.

Indexed at, Google Scholar, Crossref

8. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States. N Engl J Med 361: 1935-1944.

Indexed at, Google Scholar, Crossref

9. Jade F, Andrew M, Lindsay B, Noreen AH, Donald P, et al. (2022)The Use of Temperature and Pressure Data Loggers to Validate the Steam Sterilization of Category A Clinical Waste. Appl Biosaf 27: 106-115.

Indexed at, Google Scholar, Crossref

10. Burke DS, Nisalak A, Johnson DE, Scott RM (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.

Indexed at, Google Scholar, Crossref